tirzepatide and insulin a novel anti diabetic molecule unfold dual action | Discover Public Health Type 2 diabetes: Adding Mounjaro

What's striking is that patients are essentially running an uncoordinated global experiment and reporting results in real time, while the clinical infrastructure to make sense of it is years behind

Notice that even at the maximum dose of 15mg, you are drawing less than 0.9 mL

& Sunna, A

SURMOUNT-4 supports this: continued treatment maintained and extended the result, while stopping was commonly followed by regain

What remains unclear is how, exactly, GLP-1s deliver those cardiovascular benefits

As a result, existing players in the GLP-1 market find it increasingly challenging to sustain their market positions amidst growing affordability from generics